ALNY

ALNYLAM PHARMACEUTICALS INC

Healthcare | Large Cap

$1.56

EPS Forecast

$1,444

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$1.56

Revenue Forecast:

$1,444

EPS Surprise Forecast:

$0.102

Revenue Surprise Forecast:

-$5

Post-release price volatility - Very high

Post-release Overnight Move:

±10.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

67%

Probability of beating revenue consensus:

46%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

25%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-5

Beta (β)

Forward Looking Beta (β):

0.93

Earnings volatility

EPS standard deviation:

$0.71

Revenue standard deviation:

$67

As % of share price:

0.31% HIGH

As % of market cap:

0.22% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$2.57

Revenue 95th %ile:

$1,542

EPS 75th %ile:

$1.83

Revenue 75th %ile:

$1,471

EPS 25th %ile:

$1.38

Revenue 25th %ile:

$1,421

EPS 5th %ile:

$0.89

Revenue 5th %ile:

$1,364

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

64% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$16

Bid-ask per Share:

$0.36